Loading...
Lantheus Holdings, Inc.
LNTH•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$72.93
$2.00(2.82%)
Lantheus Holdings, Inc. (LNTH) Financial Performance & Income Statement Overview
Review Lantheus Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
18.32%
↑ 18.32%
Operating Income Growth
25.32%
↑ 25.32%
Net Income Growth
-4.35%
↓ 4.35%
Operating Cash Flow Growth
78.45%
↑ 78.45%
Operating Margin
29.43%
↑ 29.43%
Gross Margin
64.04%
↑ 64.04%
Net Profit Margin
16.55%
↑ 16.55%
ROE
22.82%
↑ 22.82%
ROIC
25.03%
↑ 25.03%
Lantheus Holdings, Inc. (LNTH) Income Statement & Financial Overview
Review Lantheus Holdings, Inc.'s (LNTH) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $391.11M | $378.73M | $394.09M | $369.98M |
| Cost of Revenue | $142.56M | $136.61M | $138.32M | $118.20M |
| Gross Profit | $248.54M | $242.13M | $255.77M | $251.78M |
| Gross Profit Ratio | $0.64 | $0.64 | $0.65 | $0.68 |
| R&D Expenses | $35.33M | $24.15M | $60.60M | $48.02M |
| SG&A Expenses | $101.51M | $84.23M | $92.54M | $93.44M |
| Operating Expenses | $134.67M | $108.38M | $153.15M | $151.40M |
| Total Costs & Expenses | $279.40M | $244.99M | $291.46M | $269.59M |
| Interest Income | $9.56M | $9.80M | $8.92M | $8.55M |
| Interest Expense | $5.04M | $4.90M | $4.86M | $4.86M |
| Depreciation & Amortization | $17.29M | $17.07M | $14.82M | $15.45M |
| EBITDA | $21.55M | $198.10M | $104.06M | $191.57M |
| EBITDA Ratio | $0.06 | $0.52 | $0.26 | $0.52 |
| Operating Income | $113.87M | $133.74M | $102.63M | $100.38M |
| Operating Income Ratio | $0.29 | $0.35 | $0.26 | $0.27 |
| Other Income/Expenses (Net) | -$114.66M | $42.38M | -$18.36M | $70.89M |
| Income Before Tax | -$783000.00 | $176.12M | $84.37M | $171.27M |
| Income Before Tax Ratio | -$0.002 | $0.47 | $0.21 | $0.46 |
| Income Tax Expense | $11.007M | $45.02M | $22.30M | $40.20M |
| Net Income | -$11.79M | $131.09M | $62.07M | $131.07M |
| Net Income Ratio | -$0.03 | $0.35 | $0.16 | $0.35 |
| EPS | -$0.17 | $1.89 | $0.90 | $1.91 |
| Diluted EPS | -$0.17 | $1.79 | $0.88 | $1.87 |
| Weighted Avg Shares Outstanding | $69.22M | $69.46M | $69.36M | $68.76M |
| Weighted Avg Shares Outstanding (Diluted) | $69.22M | $73.06M | $70.60M | $70.09M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan